Macular Hole and Epiretinal Membrane

The macula — that small, dense patch of photoreceptors at the center of the retina — is responsible for the sharp, detailed vision humans rely on for reading, recognizing faces, and driving. When its structure breaks down, the consequences are immediate and often alarming. Macular holes and epiretinal membranes (ERMs) are two distinct conditions that disrupt this architecture, each through a different mechanism, yet both capable of significantly degrading central visual acuity. The National Eye Institute estimates that macular holes affect approximately 3 in 1,000 people over age 55, with women affected at roughly twice the rate of men (NEI).

What Is a Macular Hole?

A macular hole is exactly what the name suggests — a full-thickness defect in the retinal tissue at the fovea, the very center of the macula. The fovea is where cone photoreceptor density peaks, which is why even a small structural breach there can cause disproportionate visual disruption.

The most common cause is age-related changes in the vitreous humor, the gel-like substance filling the eye. As people age, the vitreous gradually liquefies and shrinks, pulling away from the retina in a process called posterior vitreous detachment (PVD). In most cases, PVD is harmless. But when the vitreous adhesion at the fovea is particularly strong, that separation can exert enough tractional force to tear through the retinal layers — producing a hole that typically measures between 250 and 400 micrometers in diameter at full development (American Academy of Ophthalmology).

Gass's original staging system, still in clinical use, classifies macular holes from Stage 1 (impending) through Stage 4 (full-thickness with complete vitreous detachment). Symptoms progress accordingly: early stages may produce only mild central blurring or metamorphopsia (the perception that straight lines appear wavy), while a Stage 3 or 4 hole typically results in a central scotoma — a distinct blind spot directly in the line of sight.

What Is an Epiretinal Membrane?

An epiretinal membrane, sometimes called a "macular pucker" or cellophane maculopathy, is a thin fibrocellular proliferation that forms on the inner surface of the retina over the macular area. Unlike a macular hole, it doesn't breach the retinal tissue — it grows on top of it, contracting like a piece of shrink wrap and distorting the underlying architecture.

ERMs are more common than macular holes. Population-based studies, including the Blue Mountains Eye Study conducted in Australia, found ERM prevalence of approximately 7% in people over age 49, rising to nearly 12% in those over 70 (Blue Mountains Eye Study, published in Ophthalmology). The condition is often idiopathic, but known associations include previous retinal detachment, laser photocoagulation, uveitis, and — somewhat ironically — prior PVD, the same process implicated in macular holes.

The fibrocellular tissue that makes up an ERM is largely composed of glial cells, retinal pigment epithelium cells, and myofibroblasts that have migrated through small breaks in the inner limiting membrane. As the membrane contracts, it can cause retinal folds, thickening, and the distortion of foveal contour that patients describe as images appearing warped, smaller than expected (micropsia), or slightly magnified (macropsia).

Diagnosis: Where OCT Changed Everything

Optical coherence tomography (OCT) transformed the diagnostic precision available to retinal specialists. Before OCT became widely available in the 1990s and 2000s, macular holes and ERMs were diagnosed primarily through biomicroscopy and the Watzke-Allen slit-beam test. OCT now provides cross-sectional images of retinal architecture at near-histological resolution — typically around 5 to 7 micrometers axially — allowing clinicians to measure hole diameter, assess ERM thickness, evaluate foveal contour disruption, and monitor changes over time (NEI).

This matters clinically because hole size directly informs surgical planning. A macular hole under 250 micrometers is classified as small; those between 250 and 400 micrometers are medium; those exceeding 400 micrometers are large, and large holes carry a meaningfully lower rate of anatomical closure after surgery.

Treatment

Macular Holes

The standard of care for symptomatic full-thickness macular holes is pars plana vitrectomy (PPV), a microsurgical procedure in which the vitreous is removed, the inner limiting membrane is peeled to relieve traction, and a gas bubble is injected to tamponade the hole while it heals. Closure rates for small to medium holes exceed 90% with modern technique (American Academy of Ophthalmology). Patients typically face a postoperative face-down positioning requirement lasting 5 to 14 days — uncomfortable, but critical to keeping the gas bubble in contact with the hole.

Visual recovery is gradual and not always complete. Holes that have been present for less than 6 months before repair tend to achieve better final acuity than those with longer durations of symptoms.

Epiretinal Membranes

Mild ERMs with minimal symptoms are often managed with observation and serial OCT monitoring. When visual acuity drops to 20/40 or worse, or when metamorphopsia becomes functionally limiting, vitrectomy with membrane peeling is indicated. Surgical outcomes are generally favorable; a majority of patients experience measurable improvement in both acuity and distortion, though complete resolution of metamorphopsia is not guaranteed. Some degree of residual distortion persists in a meaningful subset of surgically treated patients, an outcome area under active investigation (MedlinePlus, National Library of Medicine, NLM).

FAQ

How can a macular hole be distinguished from an epiretinal membrane without imaging?

Clinically, the two can overlap in presentation — both cause central blurring and metamorphopsia. However, a macular hole typically produces a central scotoma (an area of absent vision), which an ERM rarely does. The Amsler grid test can reveal both distortion and scotoma, but OCT is required for definitive differentiation.

Does an epiretinal membrane always require surgery?

No. A significant proportion of ERMs remain stable over years without progressing to the point of functional impairment. The decision to operate depends on the severity of symptoms, documented decline in visual acuity, and the patient's own tolerance of the distortion.

Can a macular hole close on its own?

Spontaneous closure occurs in approximately 4 to 11.5% of Stage 1 (impending) macular holes, according to natural history studies. Full-thickness holes (Stages 3 and 4) rarely close without surgical intervention.

Is there a relationship between the two conditions?

Yes — an epiretinal membrane can, in some cases, produce enough foveal traction to contribute to the development of a lamellar macular hole (a partial-thickness defect). True full-thickness macular holes associated with ERMs are less common but do occur and can complicate surgical planning.

References

• National Eye Institute — Macular Hole
• American Academy of Ophthalmology — Macular Hole
• MedlinePlus / National Library of Medicine — Epiretinal Membrane
• Blue Mountains Eye Study — Mitchell P, et al. Ophthalmology 1997
• National Eye Institute — How the Eye Works

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)